Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Docetaxel

SKU: orb1309994

Description

Docetaxel is a semi-synthetic taxane that stabilizes microtubules, inhibiting their depolymerization with an IC50 of 0.2 µM. It promotes apoptosis by downregulating bcl-2 and bcl-xL, demonstrating potent anti-tumor activity in both cellular assays and animal models for cancer research.

Research Area

Cell Biology

Images & Validation

Key Properties

CAS Number114977-28-5
MW807.9
Purity>98%
FormulaC43H53NO14
SMILESO(C(C)=O)[C@]12[C@]3([C@H](OC(=O)C4=CC=CC=C4)[C@@]5(O)C(C)(C)C([C@@H](O)C(=O)[C@]3(C)[C@@H](O)C[C@]1(OC2)[H])=C(C)[C@@H](OC([C@@H]([C@@H](NC(OC(C)(C)C)=O)C6=CC=CC=C6)O)=O)C5)[H]
TargetCytoskeleton
SolubilitySoluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 25 mg/ml).

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Taxotere; RP-56976; NSC-628503

Similar Products

  • Docetaxel trihydrate [orb1310857]

    98.68% (May vary between batches)

    148408-66-6

    861.95

    C43H59NO17

  • FRAX1036 [orb1223304]

    >98% (HPLC)

    1432908-05-8

    518.05

    C28H32ClN7O

  • PF-03084014 [orb1223350]

    >98% (HPLC)

    1290543-63-3

    489.64

    C27H41F2N5O

  • DUPA(OtBu)-OH [orb1219180]

    >98% (HPLC)

    1026987-94-9

    488.57

    C23H40N2O9

Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Silvia Breusa a b , Eloise Thomas a , Noemi Baldinotti a , Serena Zilio a 1 , Jean-Guy Delcros c , Diana Marcela Hernandez-Palomino d , Weisha Qi e , Hanäé Guérin a , Benjamin Gibert b f , Patrick Mehlen b g , Ilaria Marigo d e , David Kryza a h , Giovanna Lollo Anti-Netrin-1 decorated nanoparticles combined with chemotherapy for the treatment of triple-negative breast cancer Biomaterials Advances, (2024)

Docetaxel (orb1309994)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Available Sizes

Select a size below

10 mg
$ 170.00
50 mg
$ 320.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry